These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35260267)

  • 1. Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States.
    Walker J; Paul P; Dooling K; Oliver S; Prasad P; Steele M; Gastañaduy PA; Johansson MA; Biggerstaff M; Slayton RB
    Vaccine; 2022 Mar; 40(14):2134-2139. PubMed ID: 35260267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Advisory Committee on Immunization Practices' Updated Interim Recommendation for Allocation of COVID-19 Vaccine - United States, December 2020.
    Dooling K; Marin M; Wallace M; McClung N; Chamberland M; Lee GM; Talbot HK; Romero JR; Bell BP; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jan; 69(5152):1657-1660. PubMed ID: 33382671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal SARS-CoV-2 vaccine allocation using real-time attack-rate estimates in Rhode Island and Massachusetts.
    Tran TN; Wikle NB; Albert E; Inam H; Strong E; Brinda K; Leighow SM; Yang F; Hossain S; Pritchard JR; Chan P; Hanage WP; Hanks EM; Boni MF
    BMC Med; 2021 Jul; 19(1):162. PubMed ID: 34253200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated Number of COVID-19 Infections, Hospitalizations, and Deaths Prevented Among Vaccinated Persons in the US, December 2020 to September 2021.
    Steele MK; Couture A; Reed C; Iuliano D; Whitaker M; Fast H; Hall AJ; MacNeil A; Cadwell B; Marks KJ; Silk BJ
    JAMA Netw Open; 2022 Jul; 5(7):e2220385. PubMed ID: 35793085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who should be prioritized for COVID-19 vaccination in China? A descriptive study.
    Yang J; Zheng W; Shi H; Yan X; Dong K; You Q; Zhong G; Gong H; Chen Z; Jit M; Viboud C; Ajelli M; Yu H
    BMC Med; 2021 Feb; 19(1):45. PubMed ID: 33563270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adults Hospitalized With Coronavirus Disease 2019 (COVID-19)-United States, March-June and October-December 2020: Implications for the Potential Effects of COVID-19 Tier-1 Vaccination on Future Hospitalizations and Outcomes.
    Sami S; Tenforde MW; Talbot HK; Lindsell CJ; Steingrub JS; Shapiro NI; Ginde AA; Douin DJ; Prekker ME; Erickson HL; Brown SM; Peltan ID; Gong MN; Khan A; Exline MC; Files DC; Gibbs KW; Rice TW; Casey JD; Grijalva CG; Stubblefield WB; Womack KN; Hager DN; Qadir N; Chang SY; Henning DJ; Wilson JG; Self WH; Patel MM
    Clin Infect Dis; 2021 Jul; 73(Suppl 1):S32-S37. PubMed ID: 33977301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines - United States, October 2022.
    Rosenblum HG; Wallace M; Godfrey M; Roper LE; Hall E; Fleming-Dutra KE; Link-Gelles R; Pilishvili T; Williams J; Moulia DL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley MF; Meyer S; Oliver SE; Twentyman E
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1436-1441. PubMed ID: 36355612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Consolidated recommendations of the Advisory Committee on Vaccines and Immunization Strategies- on prioritizing COVID-19 vaccination].
    Dabanch J; Bastías M; Endeiza ML; Díaz E; Inostroza J; Cerda J; Santillana S; Rodríguez J; González C; Rodríguez M; Pizarro A
    Rev Chilena Infectol; 2021 Apr; 38(2):185-188. PubMed ID: 34184708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices - United States, December 2021.
    Oliver SE; Wallace M; See I; Mbaeyi S; Godfrey M; Hadler SC; Jatlaoui TC; Twentyman E; Hughes MM; Rao AK; Fiore A; Su JR; Broder KR; Shimabukuro T; Lale A; Shay DK; Markowitz LE; Wharton M; Bell BP; Brooks O; McNally V; Lee GM; Talbot HK; Daley MF
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(3):90-95. PubMed ID: 35051137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years - United States, July 2022.
    Twentyman E; Wallace M; Roper LE; Anderson TC; Rubis AB; Fleming-Dutra KE; Hall E; Hsu J; Rosenblum HG; Godfrey M; Archer WR; Moulia DL; Daniel L; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(31):988-992. PubMed ID: 35925807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
    Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
    Link-Gelles R; Ciesla AA; Fleming-Dutra KE; Smith ZR; Britton A; Wiegand RE; Miller JD; Accorsi EK; Schrag SJ; Verani JR; Shang N; Derado G; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(48):1526-1530. PubMed ID: 36454688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of COVID-19 mRNA Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults During SARS-CoV-2 Omicron Predominance - VISION Network, 10 States, December 2021-August 2022.
    Britton A; Embi PJ; Levy ME; Gaglani M; DeSilva MB; Dixon BE; Dascomb K; Patel P; Schrader KE; Klein NP; Ong TC; Natarajan K; Hartmann E; Kharbanda AB; Irving SA; Dickerson M; Dunne MM; Raiyani C; Grannis SJ; Stenehjem E; Zerbo O; Rao S; Han J; Sloan-Aagard C; Griggs EP; Weber ZA; Murthy K; Fadel WF; Grisel N; McEvoy C; Lewis N; Barron MA; Nanez J; Reese SE; Mamawala M; Valvi NR; Arndorfer J; Goddard K; Yang DH; Fireman B; Ball SW; Link-Gelles R; Naleway AL; Tenforde MW
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(42):1335-1342. PubMed ID: 36264840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of reported severe adverse events after immunization with SARS-CoV-2 vaccines in the United States: One year on.
    Mangat HS; Musah A; Luedtke S; Syed AA; Maramattom BV; Maruthanal J; Bosman A; Kostkova P
    Front Public Health; 2022; 10():972464. PubMed ID: 36311588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Strategies for Transitioning to Annual SARS-CoV-2 Vaccination Campaigns in the United States.
    Wells CR; Pandey A; Moghadas SM; Fitzpatrick MC; Singer BH; Galvani AP
    Ann Intern Med; 2024 May; 177(5):609-617. PubMed ID: 38527289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A summary of the Advisory Committee for Immunization Practices (ACIP) use of a benefit-risk assessment framework during the first year of COVID-19 vaccine administration in the United States.
    Wallace M; Rosenblum HG; Moulia DL; Broder KR; Shimabukuro TT; Taylor CA; Havers FP; Meyer SA; Dooling K; Oliver SE; Hadler SC; Gargano JW
    Vaccine; 2023 Oct; 41(44):6456-6467. PubMed ID: 37527956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of mRNA COVID-19 Vaccine After Reports of Myocarditis Among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices - United States, June 2021.
    Gargano JW; Wallace M; Hadler SC; Langley G; Su JR; Oster ME; Broder KR; Gee J; Weintraub E; Shimabukuro T; Scobie HM; Moulia D; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2021 Jul; 70(27):977-982. PubMed ID: 34237049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interim Recommendations of the Advisory Committee on Immunization Practices for Use of Moderna and Pfizer-BioNTech COVID-19 Vaccines in Children Aged 6 Months-5 Years - United States, June 2022.
    Fleming-Dutra KE; Wallace M; Moulia DL; Twentyman E; Roper LE; Hall E; Link-Gelles R; Godfrey M; Woodworth KR; Anderson TC; Rubis AB; Shanley E; Jones JM; Morgan RL; Brooks O; Talbot HK; Lee GM; Bell BP; Daley M; Meyer S; Oliver SE
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(26):859-868. PubMed ID: 35771731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing COVID-19 vaccine allocation strategies in India: A mathematical modelling study.
    Foy BH; Wahl B; Mehta K; Shet A; Menon GI; Britto C
    Int J Infect Dis; 2021 Feb; 103():431-438. PubMed ID: 33388436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.